Yi Anita Zhao, CPA, is the Director of SEC Reporting and Technical Accounting at Denali Therapeutics, a role they have held since 2024. Previously, they served as a Senior Associate at C.G. Uhlenberg LLP from 2011 to 2013, where they co-chaired an audit system implementation and managed high-profile audit cases. With extensive experience in U.S. GAAP and IFRS, Zhao is recognized for leading execution excellence across multinational organizations.
Location
United States
This person is not in any offices